Next Generation Rocklatan
Public ClinicalTrials.gov record NCT06441643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Prospective, Two-Stage, Double-Masked, Randomized, Multi-Center, Controlled, Dose-Response Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-17043 and PG043 (AR-17043/Latanoprost) Ophthalmic Solutions in Subjects With Elevated Intraocular Pressure
Study identification
- NCT ID
- NCT06441643
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Alcon Research
- Industry
- Enrollment
- 426 participants
Conditions and interventions
Conditions
Interventions
- AR-17043 Ophthalmic Solution Drug
- PG043 Ophthalmic Solution Drug
- Latanoprost 0.005% Ophthalmic Solution Drug
- Netarsudil 0.02% Ophthalmic Solution Drug
- Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic Solution Drug
- AR-17043 Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 3, 2024
- Primary completion
- Nov 13, 2025
- Completion
- Nov 13, 2025
- Last update posted
- Nov 17, 2025
2024 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Orange County Ophthalmology Medical Group | Garden Grove | California | 92843 | — |
| United Medical Research Institute | Inglewood | California | 90301 | — |
| Eye Research Foundation | Newport Beach | California | 92663 | — |
| North Bay Eye Associates | Petaluma | California | 94954 | — |
| Eye Center of Northern Colorado, PC | Fort Collins | Colorado | 80528 | — |
| Coastal Research Associates | Roswell | Georgia | 30076 | — |
| Rochester Ophthalmological Group | Rochester | New York | 14618 | — |
| James D. Branch Ophthalmology | Winston-Salem | North Carolina | 27101 | — |
| Scott & Christie and Associates, PC | Cranberry Township | Pennsylvania | 16066 | — |
| University Eye Specialists | Maryville | Tennessee | 37803 | — |
| Total Eye Care PA | Memphis | Tennessee | 38119 | — |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06441643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06441643 live on ClinicalTrials.gov.